Rethinking pediatric clinical trials: guidelines from pediatric experts
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Overcoming challenges in long-lasting pediatric clinical trials – Insights from site experts
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s Hospital (Spain), and Vivienne Van de Walle, pediatrician and Director/Research Physician at the independent research site PreCare Trial & Recruitment (The Netherlands), bring decades of combined expertise to explore the enduring journey of pediatric clinical trials and the unique challenges faced by the young patients involved.
Check out the “Clinical Trial Chronicles” podcast on Spotify for more insights on clinical trials!
Learn more:
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Integrating PROs into studies on MASH, also known as NASH, is crucial. MASH is a debilitating
Asthma clinical trials present several specificities, such as the use of disease-specific health-related quality of
NonAlcoholic SteatoHepatitis (NASH), now called Metabolic Dysfunction-Associated SteatoHepatitis (MASH), affects almost 115 million adults globally
In this second episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Last update : 26 March 2024